Brian J. Capaldo

1.3k total citations
26 papers, 439 citations indexed

About

Brian J. Capaldo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Brian J. Capaldo has authored 26 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Brian J. Capaldo's work include Prostate Cancer Treatment and Research (9 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Brian J. Capaldo is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Brian J. Capaldo collaborates with scholars based in United States, Japan and Chile. Brian J. Capaldo's co-authors include Michael J. Weber, Mark J. Axelrod, Lisa J. Workman, Rachana Agrawal, Judith A. Woodfolk, Alexander J. Schuyler, Lyndsey M. Muehling, Jacob D. Eccles, Emanuel F. Petricoin and Stefan Bekiranov and has published in prestigious journals such as Blood, Immunity and PLoS ONE.

In The Last Decade

Brian J. Capaldo

23 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian J. Capaldo United States 11 155 140 122 104 89 26 439
Katrin Friedbichler Austria 9 187 1.2× 114 0.8× 29 0.2× 39 0.4× 158 1.8× 13 412
Stephanie Brandal United States 13 144 0.9× 123 0.9× 38 0.3× 170 1.6× 19 0.2× 31 419
Ning‐ning Shan China 15 135 0.9× 203 1.4× 21 0.2× 52 0.5× 86 1.0× 49 603
Natalie Stickel Germany 9 259 1.7× 184 1.3× 17 0.1× 34 0.3× 95 1.1× 11 550
Minjia Sheng China 8 178 1.1× 131 0.9× 21 0.2× 26 0.3× 158 1.8× 12 433
S Wade Ireland 12 204 1.3× 230 1.6× 16 0.1× 42 0.4× 99 1.1× 21 610
Chia-Li Yu Taiwan 8 111 0.7× 107 0.8× 16 0.1× 51 0.5× 98 1.1× 11 334
Manali Rupji United States 13 186 1.2× 77 0.6× 13 0.1× 111 1.1× 165 1.9× 45 479
Gillian McNab United Kingdom 10 187 1.2× 235 1.7× 18 0.1× 44 0.4× 135 1.5× 11 620

Countries citing papers authored by Brian J. Capaldo

Since Specialization
Citations

This map shows the geographic impact of Brian J. Capaldo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian J. Capaldo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian J. Capaldo more than expected).

Fields of papers citing papers by Brian J. Capaldo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian J. Capaldo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian J. Capaldo. The network helps show where Brian J. Capaldo may publish in the future.

Co-authorship network of co-authors of Brian J. Capaldo

This figure shows the co-authorship network connecting the top 25 collaborators of Brian J. Capaldo. A scholar is included among the top collaborators of Brian J. Capaldo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian J. Capaldo. Brian J. Capaldo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Can, Davinna L. Ligons, Hilary R. Keller, et al.. (2025). Integrin CD103 expression in naive CD8+ T cells promotes cytokine-driven acquisition of memory phenotype and effector function. Immunity. 58(11). 2734–2752.e9.
2.
Ahmad, Fahim, Kazutoshi Yamamoto, Daniel R. Crooks, et al.. (2025). Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancer. Neoplasia. 70. 101235–101235.
3.
Senatorov, Ilya S., Joel M. Bowman, Keith H. Jansson, et al.. (2024). Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit. Cell Reports Medicine. 5(12). 101868–101868. 2 indexed citations
4.
Capaldo, Brian J., et al.. (2024). Abstract 554: Determining the role of PROX1 in prostate cancer neuroendocrine trans-differentiation. Cancer Research. 84(6_Supplement). 554–554. 1 indexed citations
5.
Beshiri, Michael L., Brian J. Capaldo, Ross Lake, et al.. (2024). Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancer. Stem Cells. 42(6). 526–539. 3 indexed citations
6.
Fang, Lei, Dongmei Li, JuanJuan Yin, et al.. (2022). TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence. Cancer Gene Therapy. 29(10). 1463–1476. 9 indexed citations
7.
Whitlock, Nichelle C., Brian J. Capaldo, Anson T. Ku, et al.. (2022). Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A. Discover Oncology. 13(1). 97–97. 4 indexed citations
8.
Einstein, David J., Seiji Arai, Carla Calagua, et al.. (2021). Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors. JCO Precision Oncology. 1514–1522. 8 indexed citations
9.
Adelaiye‐Ogala, Remi, Berkley E. Gryder, Yen Thi Minh Nguyen, et al.. (2020). Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid Receptor. Molecular Cancer Therapeutics. 19(7). 1436–1447. 34 indexed citations
10.
Muehling, Lyndsey M., Peter W. Heymann, Paul W. Wright, et al.. (2020). Human TH1 and TH2 cells targeting rhinovirus and allergen coordinately promote allergic asthma. Journal of Allergy and Clinical Immunology. 146(3). 555–570. 36 indexed citations
11.
Whitlock, Nichelle C., Shana Y. Trostel, Scott Wilkinson, et al.. (2020). MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity. Oncogene. 39(34). 5663–5674. 20 indexed citations
12.
Balogh, Péter, Emmalee R. Adelman, John V. Pluvinage, et al.. (2019). RUNX3 levels in human hematopoietic progenitors are regulated by aging and dictate erythroid-myeloid balance. Haematologica. 105(4). 905–913. 12 indexed citations
13.
Bilchick, Kenneth C., et al.. (2019). Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1β in heart failure. Cardiovascular Research. 116(7). 1311–1322. 9 indexed citations
14.
Tyler, Christopher J., Tamara Pérez-Jeldres, Erik Ehinger, et al.. (2018). Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 24(11). 2366–2376. 8 indexed citations
15.
Jayappa, Kallesh D., Craig A. Portell, Vicki L. Gordon, et al.. (2017). Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Advances. 1(14). 933–946. 81 indexed citations
16.
Wiśniewski, J, Lyndsey M. Muehling, Jacob D. Eccles, et al.. (2017). TH1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status. Journal of Allergy and Clinical Immunology. 141(6). 2048–2060.e13. 96 indexed citations
17.
Capaldo, Brian J., Mark J. Axelrod, Alexander F. Koeppel, et al.. (2015). Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma. PLoS ONE. 10(9). e0138210–e0138210. 6 indexed citations
18.
19.
Adhikari, Neeta, Weihua Guan, Brian J. Capaldo, et al.. (2014). Identification of a New Target of miR-16, Vacuolar Protein Sorting 4a. PLoS ONE. 9(7). e101509–e101509. 9 indexed citations
20.
Axelrod, Mark J., Brian J. Capaldo, Karin Jensen, et al.. (2012). Synthetic Lethal Screening with Small-Molecule Inhibitors Provides a Pathway to Rational Combination Therapies for Melanoma. Molecular Cancer Therapeutics. 11(11). 2505–2515. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katrin Friedbichler Breakdown of academic impact, for papers by Stephanie Brandal Breakdown of academic impact, for papers by Ning‐ning Shan Breakdown of academic impact, for papers by Natalie Stickel Breakdown of academic impact, for papers by Minjia Sheng Breakdown of academic impact, for papers by S Wade Breakdown of academic impact, for papers by Chia-Li Yu Breakdown of academic impact, for papers by Manali Rupji Breakdown of academic impact, for papers by Gillian McNab
Rankless by CCL
2026